Alexander Nowak
Stock Analyst at Craig-Hallum
(2.62)
# 2,206
Out of 4,964 analysts
45
Total ratings
44.44%
Success rate
5.53%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.60 | +189.47% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $165.71 | -5.26% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.27 | +133.84% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.92 | +104.15% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $49.46 | -45.41% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $12.81 | +17.10% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.07 | +31.80% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.77 | +916.95% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $12.24 | +308.50% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $0.52 | +1,427.30% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $46.11 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.77 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.78 | +295.68% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $56.79 | +93.70% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.46 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $4.69 | +6,296.59% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.88 | +183.40% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.60
Upside: +189.47%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $165.71
Upside: -5.26%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.27
Upside: +133.84%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.92
Upside: +104.15%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $49.46
Upside: -45.41%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $12.81
Upside: +17.10%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.07
Upside: +31.80%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.77
Upside: +916.95%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $12.24
Upside: +308.50%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.52
Upside: +1,427.30%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $46.11
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.77
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.78
Upside: +295.68%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $56.79
Upside: +93.70%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.46
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $4.69
Upside: +6,296.59%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.88
Upside: +183.40%